Tus kws kho mob
P16-24 eviCore Healthcare Specialty Utilization Management (UM) Program: Cardiology and Radiology Clinical Guideline Updates
Hnub Tim pib siv tau lub khoos kas: Lub Peb Hlis Ntuj Tim 01, 2024
Tshawb Nrhiav
Nthuav pom cov txiaj ntsig tshwm sim 841 - 850 ntawm 4269
Tus kws kho mob
P15-24 New Medical, Medical Drug and Behavioral Health Policy Management Updates, Effective May 6, 2024
Hnub Tim pib siv tau lub khoos kas: Lub Peb Hlis Ntuj Tim 01, 2024
Tus kws kho mob
P14-24 Medicare Part B Step Therapy Program Expansion to Include Rystiggo, and Vyvgart Hytrulo
Hnub Tim pib siv tau lub khoos kas: Lub Peb Hlis Ntuj Tim 01, 2024
Tus kws kho mob
P54-24 Changes to the Medication Therapy Management (MTM) Program, Effective January 1, 2025
Hnub Tim pib siv tau lub khoos kas: Lub Cuaj Hlis Ntuj Tim 03, 2024
Tus kws kho mob
P57-24 MagellanRx Management, a Prime Therapeutics Company (UM) Program: Medical Drug Updates
Hnub Tim pib siv tau lub khoos kas: Lub Cuaj Hlis Ntuj Tim 03, 2024
Tus kws kho mob
2024 September Bulletins
Hnub Tim pib siv tau lub khoos kas: Lub Cuaj Hlis Ntuj Tim 03, 2024
Tus kws kho mob
P45R1-24 Updated Reimbursement Policies, Effective September 3, 2024
Hnub Tim pib siv tau lub khoos kas: Lub Cuaj Hlis Ntuj Tim 03, 2024
Tus kws kho mob
P55-24 Medical Policy Updates: Coupe Health and Self-Funded Benefit Plans Managed by Blue Cross and Blue Shield of Alabama
Hnub Tim pib siv tau lub khoos kas: Lub Cuaj Hlis Ntuj Tim 03, 2024
Tus kws kho mob
QP68-24 MHCP Pharmacy Benefit Exclusion for Kisunla™, PiaSky®, and Tecelra®
Hnub Tim pib siv tau lub khoos kas: Lub Yim Hlis Ntuj Tim 28, 2024
Tus kws kho mob
QP67-24 Commercial Pharmacy Benefit Exclusion for edaravone, Kisunla™, PiaSky®, and Tecelra®
Hnub Tim pib siv tau lub khoos kas: Lub Yim Hlis Ntuj Tim 28, 2024